The mission of the Lieber Institute for Brain Development is to translate the understanding of basic genetic and molecular mechanisms of schizophrenia and related developmental brain disorders into clinical advances that change the lives of affected individuals.
According to the World Health Organization, four of the ten most disabling diseases of world societies are psychiatric. These diseases represent an enormous economic burden but, more importantly, they involve great personal cost for affected individuals and their families. Treatments for mental disorders are inadequate in most cases and prevention is largely nonexistent.
New discoveries in developmental neurobiology and genetics put psychiatry on the threshold of a research revolution with important implications for public health.
The Lieber Institute for Brain Development (LIBD) was conceived from the realization that a new approach is needed to fully exploit the unprecedented opportunities to accomplish the critical goal of helping affected individuals and their families. The LIBD aims to transform the research landscape in two ways: by providing new tools for scientific discovery and by developing new collaborative approaches to achieve our ambitious mission.
“This is our dream, to find out what causes these disorders. And we felt it had to be a concerted effort, the study of the brain and how it develops. And this is what this institution is all about."
- Connie Lieber